Literature DB >> 6429092

The influence of fraction size in radiotherapy on the late normal tissue reaction--II: Comparison of the effects of daily and twice-a-week fractionation on human skin.

I Turesson, G Notter.   

Abstract

A comparison of the normal tissue reactions to daily and twice-a-week fractionation over 4 to 6 weeks was performed on postoperatively irradiated parasternal fields in patients with breast cancer. The radiation used was electron beams at 12-13 MeV. We have previously reported that the overall treatment time was of importance for establishment of iso-effect relationships for the acute skin erythema. In this paper we present the degree of telangiectasia after 5 years. Generally, a more pronounced late reaction was found after twice-a-week fractionation than was predicted from the acute reactions. The findings imply that the cumulative radiation effect (CRE) formula has to be modified for both acute and late reactions in certain clinical situations. The main conclusion is that the iso-effect relationship varies significantly over the dose range used in clinical radiotherapy. In the dose range of 30 fractions between 1.6 and 2.1 Gy in 6 weeks, the slope of the curve for iso-effect dose versus number of fractions varies between 0.26 and 0.35, the beta/alpha-ratios between 0.22 and 0.37 Gy-1 and the RBE 2 Fractions/week/5 Fractions/week between 1.97 and 1.82.

Entities:  

Mesh:

Year:  1984        PMID: 6429092     DOI: 10.1016/0360-3016(84)90290-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  Dose-response and dose-latency relationships for human skin after various fractionation schedules.

Authors:  I Turesson; G Notter
Journal:  Br J Cancer Suppl       Date:  1986

2.  Local therapy of rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma of children and adolescents.

Authors:  G Prindull; H G Willert; G Notter
Journal:  Eur J Pediatr       Date:  1985-07       Impact factor: 3.183

3.  Psychological distress in head and neck cancer patients 7-11 years after curative treatment.

Authors:  K Bjordal; S Kaasa
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.